Careers  |  Sign In  |  Register

Latest in Medical Students

Reuters Health • The Doctor's Channel Daily Newscast

Alemtuzumab Too Toxic for CLL Therapy

NEW YORK (Reuters Health) - After induction chemoimmunotherapy in previously untreated symptomatic patients with chronic lymphocytic leukemia (CLL), consolidation therapy with the monoclonal anti-CD52 antibody alemtuzumab (Campath-1H) improved complete response rates and reduced minimal residual disease --...

Reuters Health • The Doctor's Channel Daily Newscast

Can Bile Duct Stenting Cause Pancreatitis?

NEW YORK (Reuters Health) – Patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) and biliary stent placement are more likely to develop pancreatitis after the procedure than those not requiring a stent, according to a new study. Dr. C. Mel Wilcox and colleagues at the University of...

Reuters Health • The Doctor's Channel Daily Newscast

Benefits of candesartan for hypertension and CAD

NEW YORK (Reuters Health) – Rates of major adverse cardiovascular events (MACEs) are lower in hypertensive patients with coronary artery disease on amlodipine when candesartan is added to their treatment, a Japanese trial shows. Dr. Junichi Yamaguchi and colleagues with The Heart Institute of Japan,...